Malignant transformation: from a normal to a cancerous phenotype
As a cell or a community of cells, a biological system's hierarchical organization allows for structure formation and system functionality. Alteration of biological processes, such as cell cycle 1 or cell division, 2 may lead to fundamental disorder at the molecular level and induce activation of genetic changes ( Figure 1 ). 3 Particular hallmarks of cell transformation, tumor initiation, and subsequently progression have been related to the intricacies of cellular regulation. 4 Similarly, epigenetic alterations inducing inflammation and microenvironment changes ( Figure 2 ) have been shown to influence phenotype transformation. 5 For instance, previous reports on epigenetic transformation revealed that metastatic properties are related to the abnormal expression of key regulatory genes. Tumor-suppressor genes could, for instance, restrain cell division as well as induce cell death, while loss of gene function could result in abnormal cellular behavior, perturbation of the cell cycle, and lack of cell regulation. 6 Previous studies have also indicated that LIMD1 overexpression could retard cell-cycle progression and block S-phase entry, leading to cell accumulation in the G 0 /G 1 phase and subsequent changes in cellular behavior;
7 LIMD1 is a tumor-suppressor gene located at chromosome 3p21.3, a region commonly deleted in many malignancies. 6 Another study found that deregulation of microcephalin and ASPM expression (involved in the regulation of neurogenesis) 8 leads to abnormal cell division and subsequently to cancer progression. 7 Microcephalin is involved in the DNA-damage response and has been linked to tumor formation and cancer AGR2 is developmentally regulated initially discovered as an estrogen-responsive gene in breast cancer cell lines currently linked to tumors with poor outcome. 10 With regard to the influence of the microenvironment on cells and how changes in such microenvironments 11 could lead to phenotypic progression and cancer transformation, 12 analysis showed that alterations in external factors, such as the pH of a tissue, could trigger cellular changes 13 and regulate cell transformation. 14 An acidic environment (pH 6.5-6.9 compared with pH 7.2-7.4) could cause degradation of the extracellular matrix (ECM) and lead to the secretion of VEGF, as well as to angiogenesis, which can correlate with tumor transformation and cellular invasion ( Figure 4) . 15 Analysis also showed that proteins in the ECM could interact directly with tumor cells, eg, via their integrin surface receptors, to influence and subsequently alter cellular behavior, proliferation, apoptosis, migration, or differentiation. 16 Remodeling of the ECM could occur in tumor-fibroblast cells and subsequently accelerate cancer progression. 17 During the remodeling process, the mechanical response of the ECM can change progressively, 18 leading to enhanced cell migration 19 followed by invasion at specific interfaces. 20 Also, it was found that extracellular vesicles could regulate and modulate the microenvironment of the cancer cell 21 by regulating cellular communication and playing an important role in phenotype transformation 22 and cancer progression. 23 The malignant transformation is accompanied by changes in cell structure 24 and morphology, 25 as well as changes in cellular responses to stimuli. 26 Studies revealed that alterations in cell biophysical properties, especially in their biomechanical characteristics, represent an early indicator of disease progression, [27] [28] [29] with phenotypic events being mostly a result of cytoskeleton remodeling. 30 It was observed that BRMS1 expression in 435 cells caused changes in their architecture, leading to alterations in their biomechanical properties, with such changes being due to the reconstruction of actin cytoskeletal networks. 31 However, even though the identification of the molecular link between chronic inflammation and cancer was elucidated through NFκB, the initial transformation and activation pathways remain to be clarified and chronic inflammation-induced tumorigenesis to be elucidated. Further, while significant advances have been made toward elucidating the molecular mechanisms that underlie cancer progression, fundamental questions associated with the biomechanical traits that lead to cancer development and subsequently to metastasis remain to be answered. For instance, with tumor progression being a result of the ability of transformed cells to communicate and influence one another, as well as their neighboring healthy cells, 32 and with clinical observations of distinct tumors from different organs seeming to be cell-specific, 33 it is unclear how and whether transformation of a cell or a community of cells in an organ could lead to different tumor phenotypes or if such transformation is propagated through the microenvironment.
Biomechanical cues help identify cell transformation
With the development of atomic force microscopy (AFM) technology, computer-assisted applications for biomedical fields for analyses of biological information in terms of biomechanical characteristics have spiked. [34] [35] [36] [37] Obtaining the "bio-nano-mechanical signature" of cells or tissues has thus been proposed as the next method that could possibly lead to the development of a differentiation tool of pathological conditions from normal ones. As such, nanoindentation or the ability to detect and measure changes in the elasticity or the elastic responses of 
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AFM-based identification of cell transformation soft materials, such as cells, 38 manifested as a readout in displacement-versus-force curves ( Figure 5 ), indicated that cancer cells have different characteristics when compared to healthy cells. 26, 39 In particular, studies have shown that the stiffness, 40 migration ability, 41 and morphology 42 of cancer cells differ from healthy cells, with single cancer cells showing lower stiffness and higher deformability, 43 and with such characteristics being dependent on the type of cell being analyzed. 44 Further, complex examination of individual cells and their cellular components showed that the different elastic properties of cancer cells are a result of local or global changes that contribute to or induce their transformation. 26 Analysis of the membranes of both cancer and healthy cells showed that while the surface of the latter revealed brush-like structures of one specific length and were formed from glycocalyx layers with pericellular coatings, 45 ,46 the surface of cancer cells displayed both long and short brushes with significantly different geometries and densities. Such 
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Dong et al brush-like geometry is known to provide support for cell-cell interactions, cell migration, and differentiation. 26 Paired with changes in the cellular membrane were changes in submembrane or cytoskeletal structures. For instance, analysis of malignant (MCF7) and nonmalignant (MCF10A) breast cells revealed that MCF10A cells had an apparent Young's modulus significantly higher than that of their malignant counterparts, 47 with topographic images of such cells revealing well-structured microfilaments that were different than the ones observed for the MCF7 cells ( Figure 6 ). The differences in cytoskeletal organization were attributed to dissimilarities in the cell mechanical properties, and could possibly explain the increased migration and invasion ability of the malignant cells, especially during metastasis.
Studies also showed variations in the stiffness of the cytoskeleton of nonmalignant MCF10A and malignant MDAMB231 breast cells resulting from the growth media, 48 with analysis revealing that the mean elastic modulus of MCF10A cells was higher than that of the MDAMB231 cells cultured in identical conditions. Furthermore, the characteristics of the malignant breast cells and their nonmalignant counterparts in the 27°C-34°C temperature range 49 indicated that the malignant cells were softer than their counterparts. The significant difference in the cellular Young's modulus between malignant and healthy cells was due to the structural differences recorded, especially in their three-dimensional cytoskeleton, with the cytoskeletal structures of the cancer cells showing a more fluidlike state than the cytoskeleton of the healthy cells. 50 Membrane and cytoskeletal changes were largely accompanied by nuclear transformations, with AFM nanoindentation-based analysis of isolated nuclei of healthy (MCF10A) and malignant (MCF7) human breast epithelial cells showing mechanical changes in relation to individual cell type. 51 In particular, the apparent Young's modulus of MCF7 cell nuclei was much lower than that of MCF10A cell nuclei, mainly because of the alternation of their underlying lamina (lamin A/C) structure. The study also indicated that the nucleus' deformability was tightly related to the softening of cancer cells. Complementary AFM nanomechanical-based analysis of several areas of healthy and cancer oligodendrocytes 52 showed that the elastic modulus of the nuclear regions of the cancer cells was lower than that of the cell periphery, with cancer cells being threefold softer than healthy cells. Similar results were obtained for malignant thyroid cells, 53 with the elastic analysis showing that such malignant cells were three-to fivefold softer relative to their primary and untransformed counterparts. 54 showed that HeLa cells were three times harder than MCF7 cells.
Different prostate cancer cells showed distinctive metastatic potential, which was subsequently correlated with variations in their elastic moduli. 55 For instance, the elastic modulus of a primary benign prostate hyperplasia cell line was greater than that of the LNCaP-clone-FGC and PC3 cell lines, with the Young modulus of the highly invasive PC3 cells being higher than that of the noninvasive LNCaPclone-FGC cells. Such variations point to distinctive clinical behavior and potentially hint at different therapeutic outcomes for such cells.
When nanoindentation was used to detect cancer progression in tissue sections originating from patients, 56 analysis showed that the apparent Young modulus of the cancer region was half that of the nonneoplastic tissue. Moreover, elastic mapping conducted on healthy tissues showed homogeneous modulus profiles characterized by a single distinct peak. In contrast, malignant tissues had a distinctive broad distribution of their Young moduli mainly originating from the tissue heterogeneities, with cancer cells revealing prominent low-stiffness peaks. 57 Further, such differences in cell stiffness could also be related to identification of biomarkers with potential invasive and metastatic characteristics (Figure 7 ). 58 Bionanomechanical-based AFM functional analysis helped detect metastatic tumor cells in bodily fluids, 57 with Cross et al showing that lung, breast, and pancreas cancer cells displayed significantly decreased stiffness when compared to healthy control counterparts. 57 Rother et al investigated viscoelastic responses of nine cell lines (ie, NIH3T3 fibroblasts, MDCKII, NMuMG, A549, SW13, MCF7, MCF10A, MDAMB231, and Caki1 cells) from four different organs, all known to have variable metastatic potential, 56 ( Figure 8 ) and showed that cells from the organ exhibiting malignancy were generally softer than their benign cell counterparts. 59 When elastic moduli and cell-substrate adhesion analyses for lowly (LNCaP) and highly (CL1, CL2) metastatic human prostate cancer cells were performed, 60 results showed that the elastic moduli of CL1 and CL2 were greater than those of LNCaP, with CL1 and CL2 displaying a significantly larger area to cell-substrate adhesion relative to the LNCaP cells. The increased elastic moduli found in CL1 and CL2 were attributed to the enhanced tensile stress generated from the actin cytoskeleton anchored on more focal adhesion sites, hinting again at different metastatic potential of such cells. Complementary analysis of late-stage tumors in the lungs of mice indicated that migration and metastatic spreading characteristics were related to the low elasticity of hypoxiaassociated cancer cells. In particular, bionanomechanical showed that the Young modulus of metastatic tumor cells was about 80% lower than that of the benign cells. Moreover, cell-adhesion analysis of these malignant cells revealed an overall 33% reduced adhesion when compared to the adhesion of benign cell counterparts.
A summary of the changes in elasticity of different types of tissues and cells, all relative to controls (noncancerous cells) is in Table 1 . The results suggest that the morphology factor alone was sufficient to explain differences in stiffness for the cell types being considered and hint at mechanisms of cell invasion being based on reduced adhesion of cells to their three-dimensional environment.
Is there a next generation of AFMbased tools to be used for clinical identification of pathological conditions?
To advance AFM-based technologies for clinical detection of cell transformation, a trained workforce and consecutive probing of cell characteristics are required. However, with reports showing that such consecutive measurements can influence the mechanics of individual cells, 62 and with rigorous statistical analyses revealing that sample-preparation conditions need to be accounted for when reliability in cancer diagnosis is envisioned, the heterogeneity and complexity of a transformed cell is more than a mechanical cue indicator that permits evaluation and readability of changes in terms of cellular elasticity. As such, if AFM is to be used for advanced diagnosis and for clinical detection, the heterogeneity of the cellular sample needs to be accounted for. In particular, with analysis showing that molecular composition plays a critical role in the mechanics of the tissue, 63 for AFM to be a viable and useful tool for clinicians, analysis of the plasticity of a cell population 64, 65 needs to be supported by biochemical assays, 66 gene expression, 67 and immunofluorescent labeling. 68 Research combining AFM and biochemical assays has already shown that the interaction and bond formation of single P-selectin-ligand complexes can be quantified. P-selectin is located on the endothelial cell wall, and helps support the leukocyte when under hydrodynamic flow; the complex formed upon association with glycoproteins was shown to exhibit chain-like elasticity with a 5.3 pN⋅nm −1 molecular spring constant and a 0.35 nm persistence length. 69 Other studies indicated that DNA-dependent protein kinase can bind at the DNA termini, with such binding being characterized by AFM. 70 Also, high-speed AFM was used to reveal ATP-driven motor F 1 -rotary behavior and quantify its conformational changes, as well as confirm the dependence of the initial rates of ATP hydrolysis, as determined through biochemical assay (Figure 9 ). 71 Lastly, stretching single polysaccharides and proteins in the presence of AFM has been demonstrated, thus contributing to the body of work illustrating the biophysics and chemical biology of a protein-protein bond or enzymatic reactions related to force applications. 72 Research combining AFM with gene-expression analysis has reported on DNA condensation and how this could be used for gene therapy. 73 Polylysine covalently attached to the glycoprotein asialoorosomucoid was shown to enhance gene expression in the liver of a mouse model, with the enhancement being up to 50-fold higher when compared to polylysine alone. By combing AFM with confocal microscopy, scholars evaluated bioeffects of therapeutic ultrasound-mediated DNA 
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AFM-based identification of cell transformation on cells and nuclei, 74 with the therapeutic ultrasound proving to be useful for increasing transfection efficiency. Zhu et al mapped the nucleotide-binding site of uncoupling protein 1 with the help of AFM and using both topographic and recognition modes of the mitochondrial membrane to elucidate the mechanism of the nucleotide binding, and thus helped explain how reactive oxygen-species generation can be used for obesity-, inflammation-, neurodegeneration-, or ischemiarelated therapies. 75 Kim et al investigated fundamental structural units in the Escherichia coli nucleoid using AFM, 76 and showed that fibrous structures of 40 nm and 80 nm were found in the different growth phases of the bacteria.
Lastly, preliminary research combining AFM and immunolabeling has already demonstrated that cytoskeletal structures can be probed by combining AFM with stimulated emission depletion (STED) 77, 78 ( Figure 10 ) and/or stochastic optical reconstruction microscopy, 79 all to ensure high resolution. 80 Research has also shown that by combining AFM with immunofluorescence, both HDAC6 and its role in mediating vimentin's reorganization can be elucidated. Vimentin is known to modify the cytoskeleton structure and thus influence and regulate cellular mechanics. 81 Specifically, the authors showed that the organization of vimentin fibers in the oncogene-expressing cells was different than in the controls, with STED revealing a more entangled structure and an increase in cellular stiffness relative to controls. Such ultrahigh-resolution analysis also showed increased cellular disorganization, consistent with the 
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Dong et al possibility that oncogenes induce an HDAC6-mediated collapse of the cytoskeletal network to contribute to changes in cellular stiffness and ultimately in cell invasion that could accompany epithelial-to-mesenchymal transition. Further, Harke et al demonstrated that by combining AFM and STED, a novel advanced nanoscopic tool can be created to allow for fluorescence, topographical, and elastic-modulus analysis of biosamples. 82 Other studies also revealed cytoskeleton structures (such as actin filaments and microtubules) of living astrocytes in neural cells by coupling AFM with confocal microscopy. The results showed that the cytoskeleton fibers had high elastic moduli and demonstrated AFM's great potential to differentiate the roles of the cytoskeleton in neurodegeneration. 83 Cellwall elongation and cytoskeleton changes have also been observed for Gram-negative bacteria using superresolutionfluorescence microscopy combining AFM and stochastic optical reconstruction microscopy. 84 While this information provides evidence that AFM integration with current diagnosis assays might become a useful tool for clinicians, concerns regarding this technique's 
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AFM-based identification of cell transformation limited ability to allow for automation and real-time celltransformation analysis and evaluation, all in the natural viscoelastic conditions of both the cell and its ECM, need to be addressed. In particular, with stiffness being a function of the time scale of the measurement, 85 and knowing that well-controlled and tightly regulated balances of forces are required to help maintain homeostasis in a cell or a community of cells, 86 and with the ECM controlling survival, 87 cellular development, 88 migration, 89 proliferation, 90 shape, 91 and ultimately cellular fate and function, quantifying heterogeneity at the level of a single cell or a community of cells makes analysis even more challenging. As such, the next generation of AFM-based technologies to be considered for the identification of cell transformation should allow for possible differentiation of the different tumor elements, as well as the capability to assess how such elements can work together synergistically to contribute to or define tumor heterogeneity. For instance, such a "clinician-friendly" tool should allow for parallel tests to be performed in individual labs on chip "rooms", in which immobilized cell samples could permit evaluation of levels of protein expressions, changes in morphology, or changes in cellular elasticity ( Figure 11 ). Moreover, an ideal instrument should also allow for real-time monitoring of cellular physiological changes in a nondestructive manner and in a fast and reliable way by combining such physiological changes with the morphological and biochemical cues in a manner that could be easily interpreted by the user, ie, the clinician. Without the complexity of the biology, the analysis of mechanical cues, while perhaps providing behavioral insights, cannot provide a timedependent cell-transformation analysis nor can it allow for evaluation of heterogeneity based on the individual changes in the cell cycle.
